EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing ...
Ahead of tonight's deadline for practices to decide whether to join the Enhancing Oncology Model, CMS published a list of participants that is already outdated. A possible flaw in the model's breast ...
When the dust settled July 1, 2023, 44 physician groups, most of them large enterprises with multiple locations, had signed on to participate in the first performance period of the Enhancing Oncology ...
The Center for Medicare and Medicaid Innovation has released a new, voluntary Enhancing Oncology Model intended to reduce spending and improve quality of care for cancer patients. The EOM is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback